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Abstract
Background:  Diabetes Mellitus (DM) is a major public health problem in the UAE with a
prevalence rate reaching 24% in national citizens and 17.4% in expatriates. The aim of this study
was to determine the prevalence and risk factors of macrovascular complications among diabetic
patients in the Al-Ain district of the United Arab Emirates (UAE).
Methods: The study was part of a general cross-sectional survey carried out to assess the
prevalence of diabetes (DM) complications among known diabetic patients in Al-Ain District, UAE.
Patients were randomly selected during 2003/2004. Patients completed an interviewer-
administered questionnaire carried out by treating doctors and underwent a complete medical
assessment including measurement of height, weight, blood pressure and examination for evidence
of macrovascular complications. A standard ECG was recorded and blood samples were taken to
document fasting blood sugar, glycosylated haemoglobin (HbA1C) and lipid profile.
Results: A sample of 513 diabetic patients was selected with a mean age of 53 years (SD ± 13.01).
Overall, 29.5% of DM patients had evidence of macrovascular complications: 11.6% (95% CI: 8.8–
14.4) of patients had peripheral vascular disease (PVD), 14.4% (95% CI: 11.3–17.5) had a history of
coronary artery disease (CAD) and 3.5% (95% CI: 1.9–5.1%) had cerebrovascular disease (CVD).
Of the total population surveyed 35% (95%CI: 30.8–39) had hypertension. The analysis showed that
macrovascular complications in diabetic patients were more common among males, increased with
age, were more common among hypertensive patients and its prevalence increased steadily with
duration of DM.
Conclusion: Our data revealed a significant association between hypertension and presence of
macrovascular disease among diabetic patients. However, the risk of CAD in the UAE was
relatively low compared to that seen in patients in other geographical settings. In addition, a lack
of correlation between macrovascular disease and glycemic control among patients with DM was
observed.
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Background
DM is known to be associated with a high risk of develop-
ing vascular complications which can lead to premature
death and/or disability mainly by increasing the risk of
myocardial infarction, stroke and peripheral vascular dis-
ease [1]. Patients with DM are two to four times more
likely to develop cardiovascular disease than those in the
general population and have a two to five time's greater
risk of dying from these diseases [2].
Coronary and cerebrovascular diseases are reported to be
two to three times more common in those with DM, and
their associated mortality is also increased [1,3]. In the
worldwide INTERHEART study of patients from 52 coun-
tries, diabetes accounted for 10% of the population attrib-
utable risk of first MI [4]. Transient ischaemic attacks are
two to six times more common in DM patients and the
risk of vascular dementia is also augmented [2]. The risk
of peripheral vascular disease (PVD) in diabetics is four
times higher [5,6] and is known to increase the risk of
lower limb amputation by 15–40 times compared to the
general population [2]. In Canada, 21% of diabetic
patients were found to have heart disease and 25% of all
cardiac surgery can be attributed to diabetes [6,7].
In addition to being a risk factor for cardiovascular disease
in its own right, DM is associated with a higher prevalence
of other risk factors such as hypertension and dyslipidae-
mia, which, in turn, have a more harmful effect in the
presence of diabetes. Not only are these complications
debilitating to the patient, but they are accompanied by a
significant economic burden to the patient, family mem-
bers, and the nation's health care budget.
The prevalence of macrovascular complications among
DM patients in the UAE has not hitherto been docu-
mented. Clearly, such data are important, given that mac-
rovascular complications account for approximately 50%
of all deaths among DM patients in the industrialized
countries [2,5]. Indeed, at present it is generally upheld
that patients with DM should be treated as though they
already have heart disease. Thus, it is pertinent to deter-
mine the magnitude of macrovascular complications
among DM patients in the UAE. This is the first ever cross
sectional analysis carried out to assess the prevalence of
macrovascular complications in diabetic patients in the
UAE. The complications documented were coronary
artery disease (CAD), cerebrovascular disease (CVD) and
peripheral vascular disease (PVD) using standard proce-
dures of clinical history, physical examination, laboratory
and clinical investigations.
Methods
Overall design
The study was part of a general cross-sectional survey of
DM patients carried out to assess and establish the preva-
lence of DM complications including macrovascular com-
plications among diabetic patients in the Al-Ain District,
UAE. Al-Ain city is located in the interior of Abu Dhabi
Emirate and constitutes its second largest city (approxi-
mately 400,000 population) out of total population of
4.2 millions in the UAE. 
Subjects and setting
Multi-stage random sampling was used to select 8 primary
health care centers (PHC) in Al-Ain district (out of 22
rural and urban health care centers) in addition to two
diabetic clinics in the only two governmental hospitals in
the district (Tawam and Al-Ain hospitals). Thus, our sam-
pling frame included all UAE national and non-national
DM patients (types 1 and 2) of all ages of both genders,
attending any of the selected primary health care centers
(PHC) for any reason and diabetic clinics at the two hos-
pitals for follow up. Within these primary sampling units
(PHC and hospital clinics), a systematic random sam-
pling was carried out to select a sub-sample of patients to
be approached for participation in the study. In the
absence of a computerized database in the UAE every
third diabetic patient was approached to participate dur-
ing the study period. A sample size of 625 was calculated
to give a standard error in the prevalence of macrovascular
complications of less than 2%. In total, 600 patients were
contacted by general practitioners and diabetologists, out
of which, 513 patients (86%) agreed to enroll. The study
was approved by the Ethical Committee of the Faculty of
Medicine and Health Sciences of the UAE University. The
data were collected between September 2003 and May
2004.
Data collection
After receiving informed consent, known diabetic patients
in Al-Ain were interviewed by the treating doctors at PHC
and hospital clinics and information pertinent to their
DM type, duration, compliance with treatment as assessed
by doctors, associated complications and co-morbidity
was collected. Additionally, blood pressure was measured
by a nurse early in the morning and prior to drawing
blood samples in the sitting position, using a standard
mercury sphygmomanometer. Height was measured
without shoes, and weight recorded while wearing indoor
clothing. Body mass index (BMI) (weight in Kg, divided
by height in meters squared) was calculated. The WHO
(1977, 1979) classification for BMI was used to estimate
the degree of obesity [8]. The WHO definition of hyper-
tension [9] was used in this study: systolic blood pressure
160 mmHg or more and/or a diastolic blood pressure 95
mmHg or more, or on going treatment with antihyperten-Cardiovascular Diabetology 2007, 6:24 http://www.cardiab.com/content/6/1/24
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sive drugs. A standard 12- lead electrocardiogram (ECG)
was recorded for all patients. Fasting blood samples were
taken to assess lipid profile, blood sugar and glycated
hemoglobin (HbA1C) levels. Total lipid profile (total cho-
lesterol (TC), high density lipoprotein (HDL), TC/HDL
Ratio, low density lipoprotein (LDL) and triglycerides)
were measured by a capillary tube whole blood method
using the Cholesterol LDX lipid analyzer. Dyslipidaemia
was taken to be present when the total cholesterol was >
5.60 mmol/L and/or triglycerides > 2.10 mmol/L, LDL >
3.4 mmol/L, and or HDL < 0.91 mmol/L [10]. Glycated
hemoglobin (HbA1C) was measured using the Bayer DCA
2000+ analyzer and a value of less than 7% was taken to
indicate good glycemic control. Urinary albumin concen-
tration was measured by using semi-quantitative dry
immuno chemical screening strips (Micral 11 ® test strips
(Roche diagnostic GmbH Mannheim Germany). Micral
Tests were performed on first morning urine collections
and a value of more than 20 μg/min was judged as patho-
logical.
Macrovascular complications were ascertained using
standard procedures. Coronary artery disease was identi-
fied by symptoms of definite angina pectoris or of definite
past myocardial infarction or ECG changes consistent
with previous myocardial infarction. Cerebrovascular dis-
ease was identified by a positive answer to the query "have
you ever had a stroke?" and required confirmation by the
interviewing physician. The physician ascertained the
presence of peripheral vascular disease on physical exam-
ination when one or more foot pulses were judged absent,
or if amputation and/or gangrene were present.
Statistical analysis
The data were coded and processed on IBM compatible
computers, using the Statistical Package for Social Sci-
ences (SPSS) software (version 13). Descriptive analysis,
using standard statistical methods was performed. Chi-
square and Fisher exact tests were used to ascertain the
association between macrovascular disease and clinical
variables.
Results
Sociodemographic characteristics of the study population
A total sample (n = 513) of diabetic patients of both gen-
der and from all nationalities (UAE nationals and expatri-
ates) resident in the Al-Ain district of Abu Dhabi emirate
was selected. Of those, 52% were males, 27% aged 60
years or above (mean age 53.3), 75% were UAE nationals
and almost two thirds of patients were illiterate. Of the
total sample 12.8% (95%CI: 11.0–14.6) were current
smokers while 8.2% (95%CI: 6.7–9.7) were ex-smokers
(Table 1).
Clinical characteristics
Of the total sample, the majority (86%) had type 2 DM,
49% were diagnosed incidentally and most (79%) were
known to have had the disease for ≥ 10 years. Of the total
population, 35% (95%CI: 30.8–39) had hypertension
and 76% were obese or overweight. The majority of
patients (84%) partially managed their DM with oral
hypoglycemic agents and 24% by insulin. Two thirds were
not following any exercise regime as part of their manage-
ment plan. HbA1C results showed that 37.6 (95%CI: 32.8–
42.4) had good glycemic control and 62.4 (95%CI: 57.6–
67.2) poor control. Dyslipidaemia, as indicated by an ele-
vated total cholesterol, was present in 34.4% (95%CI:
30.0–38.8)) of patients and elevated triglycerides in
25.2% (95%CI: 21.1–29.3) (Table 2). The ratio of total
cholesterol to HDL showed that 80% were at high risk of
CAD. The ratio of LDL to HDL showed that 63% of the
population was at risk of CAD.
Prevalence of macrovascular complications
Of the total sample surveyed, 11.6% (95%CI: 9.0–14.3)
had PVD, 14.4% (95%CI: 11.3–17.5) had coronary artery
disease and 3.5% had cerebrovascular disease (CVD)
(Table 2).
The predictive risk factors for PVD, using univariate anal-
ysis were: male gender (p < 0.001), increasing age (p <
0.001), incidental DM diagnosis (p = 0.006) and duration
of diabetes (p < 0.001). Presence of hypertension was a
strong risk factor (p = 0.01).
The risk of CAD was more common among males (17%)
than females (11%) (p = 0.04), steadily increased with
increasing age (p = 0.04) and with disease duration (p =
0.002). CAD was also more common among type 1 DM
patients (25%) compared to type 2 (12%) (p = 0.007). The
risk of CAD was significantly higher among patients with
hypertension (19%) compared to those without hyperten-
sion (12%) (p = 0.04).
The overall prevalence of CVD in the sample population
was greater among males (5%) compared to females (2%)
(p = 0.02), and increased with increasing age (p = 0.02).
However, no significant association was found between
CVD and duration of DM (p = 0.45). The risk of CVD was
more common among patients with hypertension (7%)
compared to those without hypertension (2%) (p = 0.001).
The prevalence of macrovascular disease showed no sig-
nificant association with patients' nationality, level of
education, BMI, dyslipidaemia, smoking or glycemic con-
trol.Cardiovascular Diabetology 2007, 6:24 http://www.cardiab.com/content/6/1/24
Page 4 of 7
(page number not for citation purposes)
Discussion
Diabetes mellitus (DM) has long been recognized as a
major public health problem with far reaching conse-
quences, not only for its adverse health impact on individ-
uals, but also for its economic burden on the health care
system and society at large [11]. The International Diabe-
tes Federation (IDF) in 2003 ranked the UAE's prevalence
rates for type 2 DM and impaired glucose tolerance (IGT)
as the second highest in the world (20% for DM and 26%
for IGT) [2].
This study has shown an overall prevalence of macrovas-
cular disease among diabetics of 29.5%: 11.6% had PVD,
14.4% had evidence of CAD and 3.5% were considered to
have CVD. Hypertension was evident in 35% of the group;
dyslipidemia in 34% and the ratio of total cholesterol to
HDL indicated that 80% were at high risk of CAD, whilst
the ratio of LDL to HDL confirmed that 63% were at high
risk of developing CAD.
Compared to the rates reported by the WHO Multina-
tional study [12] our rate for CAD was three times lower,
our rate for CVD was consistent with the rates reported,
but our rate for PVD was twice as high as the comparative
rates. Compared to a study assessing complications
among insulin-dependent DM patients in Sudan [13] our
rates were relatively low for CAD (28%) but were consist-
ent with the rates reported for PVD (10%) and CVD (4%).
Also, our prevalence rate for CAD was consistent with the
findings of a study in Finland [14], which reported a sim-
ilar rate [16%] among type 2 DM patients after 6.3 years
of follow up.
The differences in our rates of macrovascular complica-
tions among DM patients could be attributed to differ-
ences in study design, DM patients mix, and/or
population characteristics. However, it is also possible
that the relatively low rates of CAD observed in our study
population are related to the fact that the majority of the
sample populations, (82%) were recruited from primary
health care centers and not from hospital set up.
The analysis of possible risk factors revealed a significant
association between the presence of macrovascular dis-
ease and presence of hypertension among the surveyed
diabetic population (p < 0.005). This is consistent with
results from studies in other settings elsewhere. For exam-
ple, in Spain, a large multicenter, outpatient clinics cross
sectional population study, on hypertensive and type 2
DM patients, evaluating the risk of cardiovascular disease
Table 1: Baseline Characteristics of DM Patients in Al-Ain District, UAE, 2003–2004 (n = 513).
Variable Prevalence of DM
n Percent (95% CI)
Sex
Male 264 51.5 (47.2–55.8)
Female 249 48.5 (44.2–52.8)
Level of Education
Illiterate 318 62.8 (58.6–67.0)
Completed primary school 99 19.6 (16.1–23.1)
Completed secondary school 60 11.9 (9.1–14.7)
Completed university 29 5.7 (3.7–7.7)
Age group (Years)
40 or less 81 15.8 (12.6–19.0)
41 – 49 137 26.8 (23–30.6)
50 – 59 154 30.1 (26.1–34.1)
60 or above 140 27.3 (23.4–31.2)
Nationality group
UAE 382 74.6 (70.8–78.4)
Arabian Gulf Countries Citizens 54 10.5 (7.8–13.2)
Other Arabs countries 54 10.5 (7.8–13.2)
Asians 22 4.3 (2.5–6.1)
Smoking
Current smoker 64 12.8 (11.0–14.6)
Ex smoker 41 8.2 (6.7–9.7)
BMI Group
Under weight (< 18.5) 6 1.2 (0.2–2.2)
Normal weight (18.5–24.99) 113 22.5 (18.8–26.2)
Overweight (25–29.99) 195 38.8 (34.5–43.1)
Obese (> 30) 188 37.7(33.3–41.7)Cardiovascular Diabetology 2007, 6:24 http://www.cardiab.com/content/6/1/24
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and renal damage using ECG-LVH, GFR and/or urinary
albumin excretion, was able to establish an increased
prevalence of cardiovascular disease in patients with
hypertension and type 2 DM [15].
In Iran, a hospital based study of patients admitted with
acute coronary events, established the prevalence of a sig-
nificant increase of risk of coronary artery disease among
diabetic patients compared to non diabetic patients (p <
0.005; OR = 2.4) and among hypertensive patients com-
pared to normotensive patients (p < 0.005) [16].
In Germany, a large population based study on patients
with type 2 DM, evaluating the relationship between
atherosclerotic vascular disease (AVD) and metabolic syn-
drome (single and various combinations), using AVA/
NHPLI definitions, showed an increased risk of AVD
among diabetic patients (OR for men 1.38 and for women
1.67 respectively). Interestingly, the corresponding OR for
hypertension as a single trait were 4.22 and 7.69 respec-
tively; thus proving that hypertension is highly significantly
associated with a higher prevalence of cardiovascular dis-
ease [17].
Table 2: Clinical Characteristics of DM Patients in Al Ain District, UAE, 2003–2004 (n = 513).
Variable Prevalence of DM
n Percent (95% CI)
Type of DM
Type 1 68 13.6 (10.6–16.6)
Type 2 431 86.4 (83.4–89.4)
Mode of Diagnosis
Incidental 245 48.5 (44.1–52.9)
Screening 39 7.7 (5.4–10.0)
Symptomatic 221 43.8 (39.5–48.1)
Family History of DM 
Present 270 54.3 (49.9–58.7)
Absent 227 45.7(41.3–50.1)
Duration of the DM
< 1 year 33 6.6 (4.4–8.8)
1–5 years 199 40.0 (35.7–44.3)
6–10 years 161 32.3 (28.2–36.4)
11–20 years 98 19.7 (16.2–23.4)
> 21 years 7 1.4 (0.4–2.4)
Hypertension 
Present 178 34.9 (30.0–38.8)
Absent 332 65.1(61.0–69.2)
Dyslipidaemia 
High total cholesterol level 152 34.4 (30.0–38.8)
Within reference range 290 65.5 (61.1–69.9)
Triglycerides 
High triglycerides level 105 23.9 (19.9–27.9)
Within reference range 334 76.1(72.1–80.1)
Microalbuminuria
Present 276 61.2 (56.7–65.7)
Absent 175 38.8 (34.3–43.3)
HAB1C
Good control 150 37.6 (32.8–42.4)
Poor control 249 62.4 (57.6–67.2)
Coronary Artery Disease
Present 73 14.4 (11.3–17.5)
Absent 434 85.6(82.5–88.7)
Cerebrovascular Disease
Present 18 3.5 (1.9–5.1)
Absent 490 96.5 (94.9–98.1)
Peripheral Vascular Disease
Present 59 11.6 (8.8–14.4)
Absent 451 88.5 (85.6–91.2)Cardiovascular Diabetology 2007, 6:24 http://www.cardiab.com/content/6/1/24
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By contrast we were not able to detect any association
between the presence of macrovascular disease and glyc-
emic control as determined by the level of HbA1C. Our
observation of a lack of correlation between macrovascu-
lar disease and glycemic control among patients with DM
is not unique. Indeed many longitudinal studies were
unable to establish such a link [[8,12] and [18]. The rea-
son may relate to the multifactorial nature of macrovascu-
lar complications as reported in other studies [19].
Further, unlike the experience elsewhere [20], our study
was unable to prove association between BMI, dyslipidae-
mia and cardiovascular disease in the study population;
but that is not uncommon. For example, although Lubree
et al. (2002) showed that increased levels of body fat,
using the BMI, predicted an increased level of insulin
resistance and other cardiovascular risk factors, even when
compared to waist to hip ratio (WHR) [21], other sources
suggest that the WHR is a more useful predictor of type 2
DM [22] and cardiovascular diseases [20,23]. More
recently, it has been shown that the sagittal abdominal
diameter (SAD) is the best predictor of cardiovascular risk
and mortality in men [24], the efficacy of which has been
further confirmed for women, following a recent study in
Sweden evaluating the predictive role of SAD as a marker
for CAD in the Swedish population [20]. In addition to
the noted debate, a further restriction to our study was
relating to the use of WHR, especially in women for cul-
tural reasons, to further explore the risk of cardiovascular
disease using other parameters.
The prevalence rate of CAD in our UAE diabetic patients
was rather low compared to reported rates of studies in
other geographical settings. However, this is not unique to
the UAE population alone. Evidence in the literature sug-
gests that variations in prevalence of heart diseases and
diabetes occur even within the boundaries of the same
country. For example in the US a recent study showed that
heart disease deaths were highest in the eastern parts of
the country and lowest in the west and Rocky Mountains
region [25]. Another US based study also showed signifi-
cant variations in the prevalence of DM between the north
and south; with higher rates in the southern part of the
country [26]. Among the factors considered and analyzed
were the climatic variations and temperature; though, no
clear evidence was possible to conclude [27]. Other stud-
ies considered ethnic differences to explain the variation
in the risk of cardiovascular diseases in the population
[27]. Among those was a US based study which concluded
that substantial part of the risk associated with ethnicity
can be attributed to socioeconomic status and geographi-
cal location rather than ethnicity [27].
The study had few limitations. Firstly, sampling from clin-
ics might not be representative to patients or the general
population as undiagnosed subjects might have been
excluded. Secondly, the design was cross-sectional analy-
sis, which makes it difficult to establish causal relation-
ships with certainty. Thirdly, it is known that DM is
notoriously under-diagnosed, and therefore while our
sample probably adequately reflects macrovascular com-
plications among diagnosed DM patients; it is likely that
these findings are only reflecting the tip of the iceberg.
Finally, the data from patients in Al-Ain may not typically
represent patients in all UAE regions.
Conclusion
DM in the UAE is commonly associated with macrovascu-
lar disease and hypertension. However, the risk of CAD in
UAE was relatively low compared to that seen in patients
in other geographical settings. In addition, a lack of corre-
lation between macrovascular disease and glycemic con-
trol among patients with DM was observed. Greater
awareness and attention to the macrovascular complica-
tions in patients with DM in our region is needed.
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